27.1k views
2 votes
Which of the following patient-reported outcome measurement tools has not yet been recommended in the treatment guidelines for use in clinical practice to guide clinical decisions?

A) Asthma Control Test (ACT)
B) Mini Asthma Quality of Life Questionnaire (miniAQLQ)
C) Asthma Control Questionnaire (ACT)
D) Asthma Therapy Assessment Questionnaire (ATAQ)

1 Answer

2 votes

Final answer:

Among the given options, the Asthma Therapy Assessment Questionnaire (ATAQ) is the patient-reported outcome measurement tool less commonly recommended in treatment guidelines to guide clinical decisions for asthma.

Step-by-step explanation:

The question pertains to patient-reported outcome measurement tools that are used in clinical practice to guide decisions in the treatment of asthma. Of the options provided: A) Asthma Control Test (ACT), B) Mini Asthma Quality of Life Questionnaire (miniAQLQ), C) Asthma Control Questionnaire (ACQ), and D) Asthma Therapy Assessment Questionnaire (ATAQ), there seems to be a typo in option C, as ACT has been repeated instead of ACQ. It is important to note that ACQ stands for Asthma Control Questionnaire. Among these tools, option D, the Asthma Therapy Assessment Questionnaire (ATAQ), is not as commonly recommended in treatment guidelines for use in clinical practice to guide decisions compared with the other tools mentioned.

In the treatment guidelines for asthma, the Asthma Control Test (ACT), Mini Asthma Quality of Life Questionnaire (miniAQLQ), and Asthma Control Questionnaire (ACT) have all been recommended for use in clinical practice to guide clinical decisions. However, the Asthma Therapy Assessment Questionnaire (ATAQ) has not yet been recommended in the treatment guidelines for this purpose.

the correct option is D Asthma Therapy Assessment Questionnaire (ATAQ)

User Analia
by
8.3k points

No related questions found

Welcome to QAmmunity.org, where you can ask questions and receive answers from other members of our community.